
Moderna vaccine being reviewed for emergency listing: WHO
The Hindu
A decision on the U.S. drugmaker’s vaccine was expected in one to four days, a WHO spokesperson said.
Moderna’s COVID-19 vaccine is being reviewed on April 26 by technical experts for possible WHO emergency use listing, a World Health Organization spokesperson told Reuters. “Moderna is being reviewed at the TAG (technical advisory group) meeting today,” WHO spokesman Christian Lindmeier said in reply to a query. A decision on the U.S. drugmaker’s vaccine was expected in one to four days, he said. So far, COVID-19 vaccines made by Pfizer, AstraZeneca and Johnson & Johnson have received WHO approval, which is a signal to national regulatory authorities on a product’s safety and efficacy.More Related News

The U.S. seized or intercepted three Venezuelan oil tankers — Skipper, Centuries, and Bella 1 — for carrying crude or trading with sanctioned entities. These ships are examples of the shadow fleet, showing how countries like Venezuela bypass sanctions, prompting the U.S. to order a physical blockade.












